#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Proteus syndrome Subdural haematoma Hyperadrenocorticism Pleomorphic liposarcoma Adenomatous polyposis coli Giant cell tumour of tendon sheath Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Uveal melanoma Paraganglion neoplasm Mantle cell lymphoma Stevens-Johnson syndrome Biotinidase deficiency Necrotising myositis Lymphoma Obesity More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Trials in Disease Nephrotic syndrome – Trials in Disease Breast angiosarcoma Paroxysmal nocturnal haemoglobinuria – Trials in Disease Alexander disease – Treatment Friedreich’s ataxia – Basic Information Pituitary-dependent Cushing’s syndrome – Diagnostics Marginal zone lymphoma refractory – Life with Disease Haemophilia – Life with Disease Crigler-Najjar syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SEPOFARSEN (-)-PHENSERINE TARTRATE Brinzolamide Fluvastatin Colistimethate Sodium PEGZILARGINASE Roxithromycin Amniotic Membrane, Human Triamcinolone Hexacetonide Aspartic Acid Human Immunoglobulin G Acetylsalicylic Acid Ph. Eur. Tilsotolimod Sodium Fosphenytoin Sodium Pamidronate Disodium Corticosteroids, Plain Quinidine Sulfate Deucrictibant Infliximab Letrozole More therapies…

    Learn about Your Condition

    Indolent systemic mastocytosis Stomatitis Iron overload Non-obstructive cardiomyopathy Brain cancer metastatic Penile squamous cell carcinoma Haemofiltration Gestational diabetes Endometrial cancer stage IV Muscle hypertrophy Thromboangiitis obliterans Polycystic ovarian syndrome Peripheral ischaemia Cold type haemolytic anaemia Metastases to rectum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diabetic nephropathy

  • Study on the Effects of R3R01 on Reducing Protein in Urine for Patients with Diabetic Kidney Disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Pentetic Acid
    • R3R01
    Denmark

  • Study on Aspirin’s Effect on Platelet Aggregation in Patients with Type 1 Diabetes, Atherosclerotic Cardiovascular Disease, and Diabetic Kidney Disease

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    • Type 1 diabetes mellitus
    • Arteriosclerosis
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark

  • Study on Hyperpolarized [1-13C]Pyruvate and Meglumine Gadoterate for Patients with Diabetic Kidney Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Pyruvic Acid
    • Meglumine Gadoterate
    Denmark

  • Remote Study on Empagliflozin and Finerenone for Reducing Kidney Issues in Type 2 Diabetes Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Albuminuria
    • Diabetic nephropathy
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Empagliflozin
    • Finerenone
    The Netherlands

  • Study on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic nephropathy
    Investigated Drugs:
    • Empagliflozin
    • Finerenone
    Belgium Denmark France Germany Italy The Netherlands +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!